Biopsies are typically the way prostate cancer is identified, but prostate cancers also release circulating tumor cells (CTCs) that are telltale signs of the presence of the disease. Because they’re so rare and difficult to separate from whole blood, CTCs remain rarely used for establishing diagnoses.
Researchers from the Chinese Academy of (Read more...)